SPHK1 inhibitor PF-543 blocks liver cancer progression
Jan. 11, 2024
Hepatocellular carcinoma (HCC) is characterized by a high rate of neovascularization, giving tumoral cells access to nutrients and contributing to disease progression and metastasis.